Board of Directors

Shareholdings are as of February 28, 2010, and include family members and shares held through companies. Information regarding options refers to the number of shares options held represents.

Bo Håkansson  (1946), Eslöv, Sweden. Elected 2009
Chairman from 2010.
Education: Degree in Economics and Business Administration, and Med Dr h.c., Lund University
Primary experience: Self employed since 1970. Positions as CEO, board member or chairman in different listed companies since 1986, including Wihlborg Fastigheter AB, Active Biotech AB, Midelfart Soneson AB and ACAP Invest AB. Founder of Hansa Medical AB, Active Biotech AB and ACAP Invest AB.
Other current assignments: Chairman of Biolin Scientific AB, Exini Diagnostics AB, Farstorp Invest AB, Hansa Medical AB.
Board member of Farstorps Gård AB, POC Sweden AB, Active Capital AB.
Shares in Karo Bio: 4,579,813
Independent board member

Johan Kördel (1962) Malmö, Sweden. Elected 2009
Education: M.Sc.,PhD and Associate Professor, Lund University
Primary experience: Long experience from leading positions within research and development in several international pharmaceutical companies.
Other current assignments: Chairman and CEO of Chori Pars AB, Board member of Respiratorius AB, InDex Pharmaceuticals AB and EQL Pharma AB
Shares in Karo Bio: 13,334
Independent board member

Margaret von Platen (1959) Stockholm, Sweden. Elected 2010
Education: B.Soc. Sc. Uppsala University and MBA Columbia Business School, New York
Primary experience: Financial analyst, journalist and author
Other current assignments: Board member in Nordstjernan and Världsnaturfondens Allemansfond
Shares in Karo Bio: 192,500
Independent board member

Jon Risfelt (1961), Täby, Sweden. Elected 2009
Education: M.Sc. Chemical Technology, Royal Institute of Technology, Stockholm 1985
Primary experience: Full-time board member in various companies. Prior operative senior positions include Ericsson, SAS, American Express, Nyman & Schultz (CEO), Europolitan and Vodafone Sverige (CEO) and Gambro Renal (CEO)
Other current assignments: Chairman of Ortivus AB, C3 Technologies AB, Mawell Oy. Board member of TeliaSonera AB, Bilia AB, ÅF AB, Braganza AS and Ticket Travel Group AB. More information on www.risfelt.se
Shares in Karo Bio: 7,000
Independent board member


 

Birgit Stattin Norinder (1948), London, United Kingdom. Elected 2007
Education: M.Sc. Pharm., Uppsala University
Primary experience: Long experience from leading positions within research and development in several international pharmaceutical companies. Former CEO and chairman of Prolifix Ltd.
Other engagements: Chairman of InDex Pharmaceuticals AB and P.U.L.S. AB. Board member of  Antisoma plc.
Shares in Karo Bio: none
Independent board member

Bo Carlsson (1958), Stockholm, Sweden
Employee representative, appointed 1997
Education: Specialist teacher exam, Uppsala University
Primary experience: Employed by Karo Bio since 1997, Project Manager
Shares in Karo Bio: 10,666
Employee stock options: 1,789

Johnny Sandberg (1967), Danderyd, Sweden
Employee representative, appointed 2006
Education: Biomedical analyst, Vårdhögskolan
Primary experience: Employed by Karo Bio since 2006, Senior Research Investigator
Shares in Karo Bio: 10,500
Employee stock options: 1,874